| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant therapy for resected non-small-cell lung cancer: Past, present, and future
|
Juergens, Rosalyn A.
|
|
2005
|
|
4 |
p. 248-254
|
article
|
| 2 |
Adjuvant therapy for resected non-small-cell lung cancer: Recent advances, emerging agents, and lingering questions
|
Lin, Tara L.
|
|
2004
|
|
4 |
p. 251-258
|
article
|
| 3 |
Adjuvant therapy in completely resected non-small-cell lung cancer
|
Scagliotti, Giorgio V.
|
|
2003
|
|
4 |
p. 318-325
|
article
|
| 4 |
Advances in cancer pain management
|
McDonnell, Frank J.
|
|
2000
|
|
4 |
p. 351-357
|
article
|
| 5 |
Advances in the management of malignant mesothelioma
|
Khalil, Mazen Y.
|
|
2003
|
|
4 |
p. 334-341
|
article
|
| 6 |
Angiogenesis and melanoma
|
Dutcher, Janice P.
|
|
2001
|
|
4 |
p. 353-358
|
article
|
| 7 |
Angiogenesis inhibitors in lung cancer
|
Kim, Edward S.
|
|
2002
|
|
4 |
p. 325-333
|
article
|
| 8 |
Antidepressant use in ambulatory cancer patients
|
Kim, H. Florence
|
|
2006
|
|
4 |
p. 275-281
|
article
|
| 9 |
Antisense therapy for melanoma
|
Borden, Ernest C.
|
|
2001
|
|
4 |
p. 331
|
article
|
| 10 |
Appeal by West German physicians to physicians in the USA
|
|
|
1983
|
|
4 |
p. 351-352
2 p.
|
article
|
| 11 |
Autologous and allogeneic high-dose therapy for melanoma
|
Margolin, Kim A.
|
|
2001
|
|
4 |
p. 338-343
|
article
|
| 12 |
Biochemotherapy for melanoma
|
Philip, Philip Agop
|
|
2000
|
|
4 |
p. 314-321
|
article
|
| 13 |
Cancer fatigue—more data, less information?
|
LeGrand, Susan B.
|
|
2002
|
|
4 |
p. 275-279
|
article
|
| 14 |
Cancer in the elderly: Are we ready?
|
Khayat, David
|
|
2000
|
|
4 |
p. 279-280
|
article
|
| 15 |
Cancer-related constipation
|
Thomas, Jay
|
|
2007
|
|
4 |
p. 278-284
|
article
|
| 16 |
Cancer-related fatigue: An update
|
Sood, Amit
|
|
2005
|
|
4 |
p. 277-282
|
article
|
| 17 |
Chemoprevention of lung cancer
|
Kim, Edward S.
|
|
2002
|
|
4 |
p. 341-346
|
article
|
| 18 |
Chemotherapy-induced neuropathy
|
Bhagra, Anjali
|
|
2007
|
|
4 |
p. 290-299
|
article
|
| 19 |
Clinical Trials Report
|
Meyskens, Frank L.
|
|
2001
|
|
4 |
p. 293-294
|
article
|
| 20 |
Clinical Trials Report
|
Loprinzi, Charles L.
|
|
2004
|
|
4 |
p. 275-276
|
article
|
| 21 |
Clinical Trials Report
|
Patel, Shreyaskumar R.
|
|
2004
|
|
4 |
p. 307-308
|
article
|
| 22 |
Clinical trials report
|
Loprinzi, Charles M.
|
|
2007
|
|
4 |
p. 277
|
article
|
| 23 |
Communication in advanced disease
|
LeGrand, Susan B.
|
|
2000
|
|
4 |
p. 358-361
|
article
|
| 24 |
Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer
|
MacRae, Robert
|
|
2003
|
|
4 |
p. 313-317
|
article
|
| 25 |
Contributors to this issue
|
|
|
1980
|
|
4 |
p. 383-384
2 p.
|
article
|
| 26 |
Contributors to this issue
|
|
|
1983
|
|
4 |
p. 353-354
2 p.
|
article
|
| 27 |
Critical issues in response evaluation on computed tomography: Lessons from the gastrointestinal stromal tumor model
|
Choi, Haesun
|
|
2005
|
|
4 |
p. 307-311
|
article
|
| 28 |
Current surgical management of malignant pleural mesothelioma
|
Zellos, Lambros
|
|
2002
|
|
4 |
p. 354-360
|
article
|
| 29 |
Current therapy for malignant mesothelioma
|
Smythe, W. Roy
|
|
2002
|
|
4 |
p. 305-313
|
article
|
| 30 |
Denosumab in postmenopausal women with low bone mineral density
|
Loprinzi, Charles L.
|
|
2006
|
|
4 |
p. 267-268
|
article
|
| 31 |
Developments in medical education: Issues and responses
|
Cox, Kenneth R.
|
|
1983
|
|
4 |
p. 317-328
12 p.
|
article
|
| 32 |
Do antioxidants still have a role in the prevention of human cancer?
|
Ruffin, Mack T.
|
|
2001
|
|
4 |
p. 306-313
|
article
|
| 33 |
Early results from randomized phase III trial of imatinib mesylate for gastrointestinal stromal tumors
|
Patel, Shreyaskumar R.
|
|
2003
|
|
4 |
p. 304
|
article
|
| 34 |
Epidermal growth factor receptor inhibitors and their role in non-small-cell lung cancer
|
Byrne, Brian J.
|
|
2005
|
|
4 |
p. 241-247
|
article
|
| 35 |
Estrogen receptor pathways in lung cancer
|
Stabile, Laura P.
|
|
2004
|
|
4 |
p. 259-267
|
article
|
| 36 |
Finnish reform of medical education: Implications for the united states
|
Vuori, Hannu
|
|
1980
|
|
4 |
p. 367-382
16 p.
|
article
|
| 37 |
Genomic signatures in non-small-cell lung cancer: Targeting the targeted therapies
|
Dressman, Holly K.
|
|
2006
|
|
4 |
p. 252-257
|
article
|
| 38 |
GMENAC report on U.S. physician manpower policies: Recommendations and reactions
|
Peterson, Stephen E.
|
|
1983
|
|
4 |
p. 337-349
13 p.
|
article
|
| 39 |
Handicap or disability: The davis case
|
Macleod, Marshall
|
|
1980
|
|
4 |
p. 345-349
5 p.
|
article
|
| 40 |
Hospice and health policy
|
Buckingham, Robert W.
|
|
1980
|
|
4 |
p. 303-315
13 p.
|
article
|
| 41 |
Imatinib resistance in gastrointestinal stromal tumors
|
Chen, Lei L.
|
|
2005
|
|
4 |
p. 293-299
|
article
|
| 42 |
Immunity against soft-tissue sarcomas
|
Maki, Robert G.
|
|
2003
|
|
4 |
p. 282-287
|
article
|
| 43 |
Index
|
|
|
1980
|
|
4 |
p. 385-386
2 p.
|
article
|
| 44 |
Index
|
|
|
1983
|
|
4 |
p. 355-356
2 p.
|
article
|
| 45 |
Induction chemotherapy in early stage non-small-cell lung cancer
|
Pisters, Katherine M. W.
|
|
2003
|
|
4 |
p. 307-308
|
article
|
| 46 |
Influences of a future corporate health system on medical education
|
Salmon, J. Warren
|
|
1980
|
|
4 |
p. 337-344
8 p.
|
article
|
| 47 |
Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer
|
Chang, Joe Y.
|
|
2005
|
|
4 |
p. 255-259
|
article
|
| 48 |
Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: Credits, debits, and future perspectives
|
Eggermont, Alexander M. M.
|
|
2001
|
|
4 |
p. 359-367
|
article
|
| 49 |
Limb salvage in the skeletally immature patient
|
Lewis, Valerae O.
|
|
2005
|
|
4 |
p. 285-292
|
article
|
| 50 |
Limitations to the use of the CA-125 antigen level in ovarian cancer
|
Markman, Maurie
|
|
2003
|
|
4 |
p. 263-264
|
article
|
| 51 |
Literature alert
|
|
|
2000
|
|
4 |
p. 283-285
|
article
|
| 52 |
Literature alert
|
|
|
2001
|
|
4 |
p. 288-290
|
article
|
| 53 |
Literature Alert
|
|
|
2002
|
|
4 |
p. 283-287
|
article
|
| 54 |
Literature alert
|
|
|
2003
|
|
4 |
p. 267-270
|
article
|
| 55 |
Literature alert
|
|
|
2004
|
|
4 |
p. 246-248
|
article
|
| 56 |
Lung cancer in women
|
Coscio, Angela M.
|
|
2006
|
|
4 |
p. 248-251
|
article
|
| 57 |
Lung cancer screening
|
Truong, Mylene T.
|
|
2003
|
|
4 |
p. 309-312
|
article
|
| 58 |
Lung cancer screening
|
Mazzone, Peter J.
|
|
2007
|
|
4 |
p. 265-274
|
article
|
| 59 |
Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention
|
Boyd, Norman F.
|
|
2001
|
|
4 |
p. 314-321
|
article
|
| 60 |
Management of anemia in patients with cancer
|
Steensma, David P.
|
|
2004
|
|
4 |
p. 297-304
|
article
|
| 61 |
Management of hot flashes in breast cancer survivors and men with prostate cancer
|
Stearns, Vered
|
|
2004
|
|
4 |
p. 285-290
|
article
|
| 62 |
Management of sarcomas of the head and neck
|
Brockstein, Bruce
|
|
2004
|
|
4 |
p. 321-327
|
article
|
| 63 |
Mentoring in the ethics of clinical research: An ongoing need
|
Markman, Maurie
|
|
2007
|
|
4 |
p. 235-236
|
article
|
| 64 |
Methadone for treatment of cancer pain
|
Bryson, John
|
|
2006
|
|
4 |
p. 282-288
|
article
|
| 65 |
Modern management of cancer-related intestinal obstruction
|
Davis, Mellar P.
|
|
2000
|
|
4 |
p. 343-350
|
article
|
| 66 |
Modern management of the cancer anorexia—cachexia syndrome
|
Nelson, Kristine A.
|
|
2000
|
|
4 |
p. 362-368
|
article
|
| 67 |
Molecular targets in therapy for human soft-tissue and bone sarcomas
|
Steinert, Dejka M.
|
|
2003
|
|
4 |
p. 295-303
|
article
|
| 68 |
New agents, new rashes: An update on skin complications from cancer chemotherapy
|
Patiyil, Smitha
|
|
2006
|
|
4 |
p. 269-274
|
article
|
| 69 |
New developments in melanoma genetics
|
Hayward, Nicholas
|
|
2000
|
|
4 |
p. 300-306
|
article
|
| 70 |
New therapeutic options for mesothelioma
|
Goudar, Ranjit Kumar MD
|
|
2005
|
|
4 |
p. 260-265
|
article
|
| 71 |
Novel therapeutic approaches in pediatric and young adult sarcomas
|
Anderson, Peter M.
|
|
2006
|
|
4 |
p. 310-315
|
article
|
| 72 |
Pain management, including intrathecal pumps
|
Smith, Thomas J.
|
|
2004
|
|
4 |
p. 291-296
|
article
|
| 73 |
p53 Gene therapy for lung cancer
|
Swisher, Stephen G.
|
|
2002
|
|
4 |
p. 334-340
|
article
|
| 74 |
Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer
|
Hershman, Dawn
|
|
2004
|
|
4 |
p. 277-284
|
article
|
| 75 |
Prevention of cervical cancer with vaccines
|
Im, Samuel S.
|
|
2001
|
|
4 |
p. 322-328
|
article
|
| 76 |
Prevention of non-melanoma skin cancer
|
Stratton, Steven P.
|
|
2001
|
|
4 |
p. 295-300
|
article
|
| 77 |
Preventive services: An educational or political issue?
|
Meadors, Allen C.
|
|
1983
|
|
4 |
p. 329-336
8 p.
|
article
|
| 78 |
Quality-of-life assessment in advanced cancer
|
Donnelly, Sinéad
|
|
2000
|
|
4 |
p. 338-342
|
article
|
| 79 |
Recent advances in radiotherapy for soft-tissue sarcoma
|
O’sullivan, Brian
|
|
2003
|
|
4 |
p. 274-281
|
article
|
| 80 |
Recent advances in the management of gastrointestinal stromal tumors
|
Mehren, Margaret von
|
|
2003
|
|
4 |
p. 288-294
|
article
|
| 81 |
Recombinant human erythropoietin and overall survival
|
Loprinzi, Charles L.
|
|
2005
|
|
4 |
p. 269-270
|
article
|
| 82 |
Reducing primary melanoma mortality
|
Borden, Ernest C.
|
|
2000
|
|
4 |
p. 289-291
|
article
|
| 83 |
Regional physician supply and graduate medical education
|
Lee, Robert H.
|
|
1980
|
|
4 |
p. 351-366
16 p.
|
article
|
| 84 |
Retinoid mechanisms and cyclins
|
Boyle, Jay O.
|
|
2001
|
|
4 |
p. 301-305
|
article
|
| 85 |
Review of the 2001 AJCC staging system for cutaneous malignant melanoma
|
Schuchter, Lynn M.
|
|
2001
|
|
4 |
p. 332-337
|
article
|
| 86 |
Role of education in preserving traditional cultures and as development factor
|
Haraldson, Sixten S.R.
|
|
1983
|
|
4 |
p. 289-302
14 p.
|
article
|
| 87 |
Role of gene expression arrays in sarcomas
|
Skubitz, Keith M.
|
|
2004
|
|
4 |
p. 309-314
|
article
|
| 88 |
Sarcoma molecular testing: Diagnosis and prognosis
|
Lazar, Alexander J. F.
|
|
2007
|
|
4 |
p. 309-315
|
article
|
| 89 |
Second-line therapy for advanced non-small-cell lung cancer
|
Hann, Christine L.
|
|
2006
|
|
4 |
p. 243-247
|
article
|
| 90 |
Second-line treatment of small-cell lung cancer
|
MacCallum, Cecilia
|
|
2006
|
|
4 |
p. 258-264
|
article
|
| 91 |
Soft-Tissue sarcoma in childhood and adolescence
|
Raney, R. Beverly
|
|
2002
|
|
4 |
p. 291-298
|
article
|
| 92 |
Sunitinib, a multitargeted tyrosine kinase inhibitor, in the management of gastrointestinal stromal tumor
|
George, Suzanne
|
|
2007
|
|
4 |
p. 323-327
|
article
|
| 93 |
Surgical management of primary melanoma
|
Costello, Damon
|
|
2000
|
|
4 |
p. 307-313
|
article
|
| 94 |
Surgical management of spinal mesenchymal tumors
|
Mody, Milan G.
|
|
2006
|
|
4 |
p. 297-304
|
article
|
| 95 |
Surgical resection in metastatic gastrointestinal stromal tumors
|
Choi, Eugene A.
|
|
2007
|
|
4 |
p. 303-308
|
article
|
| 96 |
Systemic therapy for advanced soft-tissue sarcomas
|
Patel, Shreyaskumar R.
|
|
2002
|
|
4 |
p. 299-304
|
article
|
| 97 |
Targeted therapy for dermatofibrosarcoma protuberans
|
Abrams, Thomas A.
|
|
2006
|
|
4 |
p. 291-296
|
article
|
| 98 |
Targeted therapy for lung cancer
|
Kukunoor, Rajesh
|
|
2003
|
|
4 |
p. 326-333
|
article
|
| 99 |
Targeted therapy for malignant melanoma
|
Brown, C. Komen
|
|
2001
|
|
4 |
p. 344-352
|
article
|
| 100 |
Targeting epidermal growth factor receptor in lung cancer
|
Baselga, José
|
|
2002
|
|
4 |
p. 317-324
|
article
|
| 101 |
Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how?
|
Juergens, Rosalyn
|
|
2007
|
|
4 |
p. 255-264
|
article
|
| 102 |
The cancer anorexia/weight loss syndrome: Therapeutic challenges
|
Giordano, Karin F.
|
|
2005
|
|
4 |
p. 271-276
|
article
|
| 103 |
The changing prognosis of melanoma
|
Buzaid, Antonio C.
|
|
2000
|
|
4 |
p. 322-328
|
article
|
| 104 |
The diagnostic "gold standard" in oncology: Increasing importance and increasing concerns
|
Markman, Maurie
|
|
2006
|
|
4 |
p. 237-238
|
article
|
| 105 |
The dying patient
|
Cowan, John D.
|
|
2000
|
|
4 |
p. 331-337
|
article
|
| 106 |
The effects of implementation problems on certificate of need decisions in Illinois
|
Colby, David C.
|
|
1983
|
|
4 |
p. 303-316
14 p.
|
article
|
| 107 |
The impact of new medical schools and the issues of increasing enrollment
|
Lostetter, John O.
|
|
1980
|
|
4 |
p. 317-336
20 p.
|
article
|
| 108 |
The role and limitations of radiofrequency ablation in treatment of bone and soft tissue tumors
|
Ahrar, Kamran
|
|
2004
|
|
4 |
p. 315-320
|
article
|
| 109 |
The role of hyperthermia in combined treatment in the management of soft tissue sarcoma
|
Issels, Rolf D.
|
|
2006
|
|
4 |
p. 305-309
|
article
|
| 110 |
The role of mTOR inhibitors for treatment of sarcomas
|
Mita, Monica M.
|
|
2007
|
|
4 |
p. 316-322
|
article
|
| 111 |
The role of surgery in the treatment of stage III non—small-cell lung cancer
|
Gallo, Amy E.
|
|
2007
|
|
4 |
p. 247-254
|
article
|
| 112 |
Three-dimensional conformal radiotherapy for lung cancer: Promises and pitfalls
|
Patel, Rakesh R.
|
|
2002
|
|
4 |
p. 347-353
|
article
|
| 113 |
Transcription factors and other dysregulated proteins in melanoma prognosis
|
Karjalainen, Jari M.
|
|
2001
|
|
4 |
p. 368-375
|
article
|
| 114 |
Transitional cell carcinoma of the bladder: New approaches to the treatment of advanced disease
|
Petrylak, Daniel P.
|
|
2001
|
|
4 |
p. 285-286
|
article
|
| 115 |
Transitions to palliation: Two solitudes or inevitable integration?
|
Rayson, Daniel
|
|
2007
|
|
4 |
p. 285-289
|
article
|
| 116 |
Translating the results of phase III randomized cancer trials into the language of physician obligation to patients
|
Markman, Maurie
|
|
2004
|
|
4 |
p. 243-244
|
article
|
| 117 |
Treatment options for brain metastases in patients with non-small-cell lung cancer
|
Taimur, Sadaf
|
|
2003
|
|
4 |
p. 342-346
|
article
|
| 118 |
Treatment options for small cell lung cancer
|
Wolf, Todd
|
|
2004
|
|
4 |
p. 268-271
|
article
|
| 119 |
Unique issues in the development of ‘targeted’ antineoplastic pharmaceutical agents
|
Markman, Maurie
|
|
2005
|
|
4 |
p. 235-236
|
article
|
| 120 |
Vaccination for melanoma
|
Thompson, Lee W.
|
|
2000
|
|
4 |
p. 292-299
|
article
|
| 121 |
Vaccine therapy in non—small-cell lung cancer
|
Albright, Carol
|
|
2007
|
|
4 |
p. 241-246
|
article
|
| 122 |
Web alert
|
|
|
2000
|
|
4 |
p. 281-282
|
article
|
| 123 |
Web alert
|
|
|
2001
|
|
4 |
p. 287
|
article
|
| 124 |
Web alert
|
|
|
2005
|
|
4 |
p. 237-238
|
article
|
| 125 |
Web alert
|
|
|
2006
|
|
4 |
p. 239-240
|
article
|
| 126 |
Web Alert
|
|
|
2002
|
|
4 |
p. 280-282
|
article
|
| 127 |
Web alert
|
|
|
2004
|
|
4 |
p. 249
|
article
|
| 128 |
Web alert
|
|
|
2007
|
|
4 |
p. 237
|
article
|
| 129 |
Web alert
|
|
|
2003
|
|
4 |
p. 265-266
|
article
|
Journal description